@prefix this: <http://www.tkuhn.ch/bel2nanopub/RA2K8gqGJog0qcLCpHfzj79OHqxmtRWv29BBCy1BoaScc> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RA2K8gqGJog0qcLCpHfzj79OHqxmtRWv29BBCy1BoaScc#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix chebi: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=> .
@prefix go: <http://amigo.geneontology.org/amigo/term/GO:> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix do: <http://disease-ontology.org/term/DOID:> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:_1 occursIn: do:1324, obo:CLO_0007986, obo:UBERON_0002048, species:9606;
    rdf:object go:0000084;
    rdf:predicate belv:increases;
    rdf:subject chebi:3722;
    a rdf:Statement .
  
  sub:assertion rdfs:label "a(CHEBI:cisplatin) -> bp(GOBP:\"mitotic S phase\")" .
}

sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
    dce:title "BEL Framework Large Corpus Document";
    pav:authoredBy sub:_3;
    pav:version "20131211" .
  
  sub:_2 prov:value "we utilized NCI-H1299 NSCLC cell lines engineered to express shRNA targeting either cdk2 or cdk1 upon doxycycline induction (Cai et al., 2006b) and assessed the degree of S-phase cell-cycle arrest after exposure to cisplatin or IR in the absence or presence of doxycycline. In the absence of doxycycline in both sets of cells, cisplatin treatment for 24 hr caused cells to accumulate in S phase (Figure 1A and see Figure S1 available online).";
    prov:wasQuotedFrom pubmed:19683496 .
  
  sub:_3 rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource pubmed:19683496;
    prov:wasDerivedFrom beldoc:, sub:_2 .
}

sub:pubinfo {
  this: dct:created "2014-07-03T14:33:36.122+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}